Trulieve Cannabis Corp. (TRLV) stock
TRLVNYSEMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 5/3033% below fair value
$10.07−0.26 (-2.52%)
Close on Nov 17, 2026Market cap $1.94BP/E –Yield –
Trulieve Cannabis cash
Cash and short-term investments held at the end of each period.
Trulieve Cannabis's cash was $325.42M at Jun 30, 2026. For fiscal 2025 it was $255.54M, down 14.6% from the year before. The highest annual figure on record is $299.20M in fiscal 2024.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $255.54M | -14.6% |
| FY2024 | Dec 31, 2024 | $299.20M | +48.6% |
| FY2023 | Dec 31, 2023 | $201.37M | -2.8% |
| FY2022 | Dec 31, 2022 | $207.19M | -8.6% |
| FY2021 | Dec 31, 2021 | $226.63M | +54.5% |
| FY2020 | Dec 31, 2020 | $146.71M | +59.8% |
| FY2019 | Dec 31, 2019 | $91.81M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $325.42M | -17.1% |
| Q1 FY2026 | Mar 31, 2026 | $352.88M | +7.4% |
| Q4 FY2025 | Dec 31, 2025 | $255.54M | -14.6% |
| Q3 FY2025 | Sep 30, 2025 | $449.20M | +41.3% |
| Q2 FY2025 | Jun 30, 2025 | $392.58M | +10.5% |
| Q1 FY2025 | Mar 31, 2025 | $328.45M | +2.5% |
| Q4 FY2024 | Dec 31, 2024 | $299.20M | +48.6% |
| Q3 FY2024 | Sep 30, 2024 | $317.85M | +65.4% |
| Q2 FY2024 | Jun 30, 2024 | $355.18M | +133.1% |
| Q1 FY2024 | Mar 31, 2024 | $320.31M | +72.5% |
| Q4 FY2023 | Dec 31, 2023 | $201.37M | -2.8% |
| Q3 FY2023 | Sep 30, 2023 | $192.16M | +90.9% |
| Q2 FY2023 | Jun 30, 2023 | $152.37M | -8.5% |
| Q1 FY2023 | Mar 31, 2023 | $185.64M | -30.3% |
| Q4 FY2022 | Dec 31, 2022 | $207.19M | -8.6% |
| Q3 FY2022 | Sep 30, 2022 | $100.66M | -52.9% |
| Q2 FY2022 | Jun 30, 2022 | $166.54M | -42.4% |
| Q1 FY2022 | Mar 31, 2022 | $266.40M | +64.0% |
| Q4 FY2021 | Dec 31, 2021 | $226.63M | +54.5% |
| Q3 FY2021 | Sep 30, 2021 | $213.57M | +132.6% |
| Q2 FY2021 | Jun 30, 2021 | $289.24M | – |
| Q1 FY2021 | Mar 31, 2021 | $162.45M | – |
| Q4 FY2020 | Dec 31, 2020 | $146.71M | – |
| Q4 FY2019 | Dec 31, 2019 | $91.81M | – |
See a number that looks wrong?